Research has shown that 5 alpha reductase inhibitors can have significant effects on the prostate. By reducing DHT levels, these drugs can help shrink enlarged prostates and may also lower the risk of developing prostate cancer. However, the relationship between these inhibitors and cancer is complex and requires a nuanced understanding.
